Vaccines against tularemia
- PMID: 19923904
- PMCID: PMC3132883
- DOI: 10.4161/hv.10297
Vaccines against tularemia
Abstract
Francisella tularensis is a Category A select agent for which vaccine and countermeasure development are a priority. In the past eight years, renewed interest in this pathogen has led to the generation of an enormous amount of new data on both the pathogen itself and its interaction with host cells. This information has fostered the development of various vaccine candidates including acellular subunit, killed whole cell and live attenuated. This review summarizes the progress and promise of these various candidates.
Similar articles
-
Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.Front Cell Infect Microbiol. 2018 May 15;8:154. doi: 10.3389/fcimb.2018.00154. eCollection 2018. Front Cell Infect Microbiol. 2018. PMID: 29868510 Free PMC article. Review.
-
Francisella tularensis vaccines.FEMS Immunol Med Microbiol. 2007 Apr;49(3):315-23. doi: 10.1111/j.1574-695X.2007.00219.x. Epub 2007 Feb 22. FEMS Immunol Med Microbiol. 2007. PMID: 17316369 Review.
-
Live attenuated tularemia vaccines: recent developments and future goals.Vaccine. 2013 Aug 2;31(35):3485-91. doi: 10.1016/j.vaccine.2013.05.096. Epub 2013 Jun 10. Vaccine. 2013. PMID: 23764535 Free PMC article. Review.
-
Vaccines against Francisella tularensis--past, present and future.Expert Rev Vaccines. 2004 Jun;3(3):307-14. doi: 10.1586/14760584.3.3.307. Expert Rev Vaccines. 2004. PMID: 15176947 Review.
-
Rationally designed tularemia vaccines.Expert Rev Vaccines. 2009 Jul;8(7):877-85. doi: 10.1586/erv.09.51. Expert Rev Vaccines. 2009. PMID: 19538114 Free PMC article. Review.
Cited by
-
Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.PLoS One. 2015 Jun 22;10(6):e0130858. doi: 10.1371/journal.pone.0130858. eCollection 2015. PLoS One. 2015. PMID: 26098553 Free PMC article.
-
Tularemia: a re-emerging tick-borne infectious disease.Folia Microbiol (Praha). 2021 Feb;66(1):1-14. doi: 10.1007/s12223-020-00827-z. Epub 2020 Sep 28. Folia Microbiol (Praha). 2021. PMID: 32989563 Free PMC article. Review.
-
Disruption of Francisella tularensis Schu S4 iglI, iglJ, and pdpC genes results in attenuation for growth in human macrophages and in vivo virulence in mice and reveals a unique phenotype for pdpC.Infect Immun. 2013 Mar;81(3):850-61. doi: 10.1128/IAI.00822-12. Epub 2012 Dec 28. Infect Immun. 2013. PMID: 23275090 Free PMC article.
-
Clusters versus affinity-based approaches in F. tularensis whole genome search of CTL epitopes.PLoS One. 2012;7(5):e36440. doi: 10.1371/journal.pone.0036440. Epub 2012 May 1. PLoS One. 2012. PMID: 22563500 Free PMC article.
-
TolC-dependent modulation of host cell death by the Francisella tularensis live vaccine strain.Infect Immun. 2014 May;82(5):2068-78. doi: 10.1128/IAI.00044-14. Epub 2014 Mar 10. Infect Immun. 2014. PMID: 24614652 Free PMC article.
References
-
- Aronova NV, Pavlovich NV. Phase variations of Francisella tularensis lipopolysaccharide in human infection and immunization. Zh Mikrobiol Epidemiol Immunobiol. 2005:8–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous